209 related articles for article (PubMed ID: 36333412)
1. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.
Joas E; Jonsson L; Viktorin A; Smedler E; Pålsson E; Goodwin GM; Landén M
Pharmacogenomics J; 2023 Jan; 23(1):28-35. PubMed ID: 36333412
[TBL] [Abstract][Full Text] [Related]
2. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Lee SH; Newhouse S; Patel H; O'Donovan M; Lewis G; Jenkins G; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Schruers K; Biernacka JM; Uher R; Lewis CM
Eur Neuropsychopharmacol; 2018 Aug; 28(8):945-954. PubMed ID: 30135031
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.
Honeycutt DC; Blom TJ; Ramsey LB; Strawn JR; Bruns KM; Welge JA; Patino LR; Singh MK; DelBello MP
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):42-51. PubMed ID: 38377518
[No Abstract] [Full Text] [Related]
4. Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.
Lloret-Linares C; Bosilkovska M; Daali Y; Gex-Fabry M; Heron K; Bancila V; Michalopoulos G; Perroud N; Richard-Lepouriel H; Aubry JM; Desmeules J; Besson M
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570971
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
Yuce-Artun N; Baskak B; Ozel-Kizil ET; Ozdemir H; Uckun Z; Devrimci-Ozguven H; Suzen HS
Int J Clin Pharm; 2016 Apr; 38(2):388-94. PubMed ID: 26830411
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Tsai MH; Lin KM; Hsiao MC; Shen WW; Lu ML; Tang HS; Fang CK; Wu CS; Lu SC; Liu SC; Chen CY; Liu YL
Pharmacogenomics; 2010 Apr; 11(4):537-46. PubMed ID: 20350136
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder.
Nuñez NA; Coombes BJ; Beaupre LM; Ozerdem A; Resendez MG; Romo-Nava F; Bond DJ; Veldic M; Singh B; Moore KM; Betcher HK; Kung S; Prieto ML; Fuentes M; Ercis M; Miola A; Sanchez Ruiz JA; Jenkins G; Batzler A; Leung JG; Cuellar-Barboza A; Tye SJ; McElroy SL; Biernacka JM; Frye MA
Transl Psychiatry; 2024 Feb; 14(1):93. PubMed ID: 38351009
[TBL] [Abstract][Full Text] [Related]
8. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
Jessel CD; Mostafa S; Potiriadis M; Everall IP; Gunn JM; Bousman CA
Pharmacogenet Genomics; 2020 Sep; 30(7):145-152. PubMed ID: 32433340
[TBL] [Abstract][Full Text] [Related]
9. CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study.
Strawn JR; Poweleit EA; Ramsey LB
J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):340-347. PubMed ID: 30817183
[No Abstract] [Full Text] [Related]
10. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
11. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Frye MA; Helleman G; McElroy SL; Altshuler LL; Black DO; Keck PE; Nolen WA; Kupka R; Leverich GS; Grunze H; Mintz J; Post RM; Suppes T
Am J Psychiatry; 2009 Feb; 166(2):164-72. PubMed ID: 19015231
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the association between treatment with antidepressants and mania: A nationwide within-individual study of 3554 patients with bipolar disorder.
Jefsen OH; Rohde C; Østergaard SD
Bipolar Disord; 2023 Nov; 25(7):583-591. PubMed ID: 37308316
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.
Bond DJ; Noronha MM; Kauer-Sant'Anna M; Lam RW; Yatham LN
J Clin Psychiatry; 2008 Oct; 69(10):1589-601. PubMed ID: 19192442
[TBL] [Abstract][Full Text] [Related]
14. Association between CYP2C19 polymorphism and depressive symptoms.
Sim SC; Nordin L; Andersson TM; Virding S; Olsson M; Pedersen NL; Ingelman-Sundberg M
Am J Med Genet B Neuropsychiatr Genet; 2010 Sep; 153B(6):1160-6. PubMed ID: 20468063
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics to Predict Adverse Events Associated With Antidepressants.
Rossow KM; Aka IT; Maxwell-Horn AC; Roden DM; Van Driest SL
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 33234666
[TBL] [Abstract][Full Text] [Related]
16. Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Ricardo-Silgado ML; Singh S; Cifuentes L; Decker PA; Gonzalez-Izundegui D; Moyer AM; Hurtado MD; Camilleri M; Bielinski SJ; Acosta A
BMC Med; 2022 Jul; 20(1):261. PubMed ID: 35879764
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
18. Influence of
Islam F; Magarbeh L; Elsheikh SSM; Kloiber S; Espinola CW; Bhat V; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Hassel S; Taylor VH; Leri F; Blier P; Uher R; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kennedy SH; Müller DJ
Can J Psychiatry; 2024 Mar; 69(3):183-195. PubMed ID: 37796764
[TBL] [Abstract][Full Text] [Related]
19. Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.
Spigset O; Hedenmalm K; Dahl ML; Wiholm BE; Dahlqvist R
Acta Psychiatr Scand; 1997 Nov; 96(5):379-84. PubMed ID: 9395157
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.
Saatcioglu O; Erim R; Tomruk N; Oral T; Alpay N
J Affect Disord; 2011 Nov; 134(1-3):85-90. PubMed ID: 21632117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
